IBDEI2I2 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39916,1,4,0)
;;=4^A60.01
;;^UTILITY(U,$J,358.3,39916,2)
;;=^5000353
;;^UTILITY(U,$J,358.3,39917,0)
;;=B00.1^^152^2002^33
;;^UTILITY(U,$J,358.3,39917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39917,1,3,0)
;;=3^Herpesviral Vesicular Dermatitis
;;^UTILITY(U,$J,358.3,39917,1,4,0)
;;=4^B00.1
;;^UTILITY(U,$J,358.3,39917,2)
;;=^5000468
;;^UTILITY(U,$J,358.3,39918,0)
;;=B97.89^^152^2002^89
;;^UTILITY(U,$J,358.3,39918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39918,1,3,0)
;;=3^Viral Agent Cause of Disease
;;^UTILITY(U,$J,358.3,39918,1,4,0)
;;=4^B97.89
;;^UTILITY(U,$J,358.3,39918,2)
;;=^5000879
;;^UTILITY(U,$J,358.3,39919,0)
;;=B97.10^^152^2002^21
;;^UTILITY(U,$J,358.3,39919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39919,1,3,0)
;;=3^Enterovirus Cause of Disease
;;^UTILITY(U,$J,358.3,39919,1,4,0)
;;=4^B97.10
;;^UTILITY(U,$J,358.3,39919,2)
;;=^5000861
;;^UTILITY(U,$J,358.3,39920,0)
;;=B34.9^^152^2002^90
;;^UTILITY(U,$J,358.3,39920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39920,1,3,0)
;;=3^Viral Infection,Unspec
;;^UTILITY(U,$J,358.3,39920,1,4,0)
;;=4^B34.9
;;^UTILITY(U,$J,358.3,39920,2)
;;=^5000603
;;^UTILITY(U,$J,358.3,39921,0)
;;=A69.20^^152^2002^50
;;^UTILITY(U,$J,358.3,39921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39921,1,3,0)
;;=3^Lyme Disease,Unspec
;;^UTILITY(U,$J,358.3,39921,1,4,0)
;;=4^A69.20
;;^UTILITY(U,$J,358.3,39921,2)
;;=^5000375
;;^UTILITY(U,$J,358.3,39922,0)
;;=A69.22^^152^2002^52
;;^UTILITY(U,$J,358.3,39922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39922,1,3,0)
;;=3^Neurologic Disorders d/t Lyme Disease
;;^UTILITY(U,$J,358.3,39922,1,4,0)
;;=4^A69.22
;;^UTILITY(U,$J,358.3,39922,2)
;;=^5000377
;;^UTILITY(U,$J,358.3,39923,0)
;;=A69.21^^152^2002^51
;;^UTILITY(U,$J,358.3,39923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39923,1,3,0)
;;=3^Meningitis d/t Lyme Disease
;;^UTILITY(U,$J,358.3,39923,1,4,0)
;;=4^A69.21
;;^UTILITY(U,$J,358.3,39923,2)
;;=^5000376
;;^UTILITY(U,$J,358.3,39924,0)
;;=A69.29^^152^2002^18
;;^UTILITY(U,$J,358.3,39924,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39924,1,3,0)
;;=3^Conditions d/t Lyme Disease
;;^UTILITY(U,$J,358.3,39924,1,4,0)
;;=4^A69.29
;;^UTILITY(U,$J,358.3,39924,2)
;;=^5000379
;;^UTILITY(U,$J,358.3,39925,0)
;;=A69.23^^152^2002^5
;;^UTILITY(U,$J,358.3,39925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39925,1,3,0)
;;=3^Arthritis d/t Lyme Disease
;;^UTILITY(U,$J,358.3,39925,1,4,0)
;;=4^A69.23
;;^UTILITY(U,$J,358.3,39925,2)
;;=^5000378
;;^UTILITY(U,$J,358.3,39926,0)
;;=A51.0^^152^2002^29
;;^UTILITY(U,$J,358.3,39926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39926,1,3,0)
;;=3^Genital Syphilis,Primary
;;^UTILITY(U,$J,358.3,39926,1,4,0)
;;=4^A51.0
;;^UTILITY(U,$J,358.3,39926,2)
;;=^5000272
;;^UTILITY(U,$J,358.3,39927,0)
;;=A52.3^^152^2002^54
;;^UTILITY(U,$J,358.3,39927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39927,1,3,0)
;;=3^Neurosyphilis,Unspec
;;^UTILITY(U,$J,358.3,39927,1,4,0)
;;=4^A52.3
;;^UTILITY(U,$J,358.3,39927,2)
;;=^5000298
;;^UTILITY(U,$J,358.3,39928,0)
;;=A52.10^^152^2002^53
;;^UTILITY(U,$J,358.3,39928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39928,1,3,0)
;;=3^Neurosyphilis Symptomatic,Unspec
;;^UTILITY(U,$J,358.3,39928,1,4,0)
;;=4^A52.10
;;^UTILITY(U,$J,358.3,39928,2)
;;=^5000291
;;^UTILITY(U,$J,358.3,39929,0)
;;=A52.9^^152^2002^49
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2I2 3784 printed Apr 09, 2024@20:56:27 Page 2
IBDEI2I2 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39916,1,4,0)
+2 ;;=4^A60.01
+3 ;;^UTILITY(U,$J,358.3,39916,2)
+4 ;;=^5000353
+5 ;;^UTILITY(U,$J,358.3,39917,0)
+6 ;;=B00.1^^152^2002^33
+7 ;;^UTILITY(U,$J,358.3,39917,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,39917,1,3,0)
+10 ;;=3^Herpesviral Vesicular Dermatitis
+11 ;;^UTILITY(U,$J,358.3,39917,1,4,0)
+12 ;;=4^B00.1
+13 ;;^UTILITY(U,$J,358.3,39917,2)
+14 ;;=^5000468
+15 ;;^UTILITY(U,$J,358.3,39918,0)
+16 ;;=B97.89^^152^2002^89
+17 ;;^UTILITY(U,$J,358.3,39918,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,39918,1,3,0)
+20 ;;=3^Viral Agent Cause of Disease
+21 ;;^UTILITY(U,$J,358.3,39918,1,4,0)
+22 ;;=4^B97.89
+23 ;;^UTILITY(U,$J,358.3,39918,2)
+24 ;;=^5000879
+25 ;;^UTILITY(U,$J,358.3,39919,0)
+26 ;;=B97.10^^152^2002^21
+27 ;;^UTILITY(U,$J,358.3,39919,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,39919,1,3,0)
+30 ;;=3^Enterovirus Cause of Disease
+31 ;;^UTILITY(U,$J,358.3,39919,1,4,0)
+32 ;;=4^B97.10
+33 ;;^UTILITY(U,$J,358.3,39919,2)
+34 ;;=^5000861
+35 ;;^UTILITY(U,$J,358.3,39920,0)
+36 ;;=B34.9^^152^2002^90
+37 ;;^UTILITY(U,$J,358.3,39920,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,39920,1,3,0)
+40 ;;=3^Viral Infection,Unspec
+41 ;;^UTILITY(U,$J,358.3,39920,1,4,0)
+42 ;;=4^B34.9
+43 ;;^UTILITY(U,$J,358.3,39920,2)
+44 ;;=^5000603
+45 ;;^UTILITY(U,$J,358.3,39921,0)
+46 ;;=A69.20^^152^2002^50
+47 ;;^UTILITY(U,$J,358.3,39921,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,39921,1,3,0)
+50 ;;=3^Lyme Disease,Unspec
+51 ;;^UTILITY(U,$J,358.3,39921,1,4,0)
+52 ;;=4^A69.20
+53 ;;^UTILITY(U,$J,358.3,39921,2)
+54 ;;=^5000375
+55 ;;^UTILITY(U,$J,358.3,39922,0)
+56 ;;=A69.22^^152^2002^52
+57 ;;^UTILITY(U,$J,358.3,39922,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,39922,1,3,0)
+60 ;;=3^Neurologic Disorders d/t Lyme Disease
+61 ;;^UTILITY(U,$J,358.3,39922,1,4,0)
+62 ;;=4^A69.22
+63 ;;^UTILITY(U,$J,358.3,39922,2)
+64 ;;=^5000377
+65 ;;^UTILITY(U,$J,358.3,39923,0)
+66 ;;=A69.21^^152^2002^51
+67 ;;^UTILITY(U,$J,358.3,39923,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,39923,1,3,0)
+70 ;;=3^Meningitis d/t Lyme Disease
+71 ;;^UTILITY(U,$J,358.3,39923,1,4,0)
+72 ;;=4^A69.21
+73 ;;^UTILITY(U,$J,358.3,39923,2)
+74 ;;=^5000376
+75 ;;^UTILITY(U,$J,358.3,39924,0)
+76 ;;=A69.29^^152^2002^18
+77 ;;^UTILITY(U,$J,358.3,39924,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,39924,1,3,0)
+80 ;;=3^Conditions d/t Lyme Disease
+81 ;;^UTILITY(U,$J,358.3,39924,1,4,0)
+82 ;;=4^A69.29
+83 ;;^UTILITY(U,$J,358.3,39924,2)
+84 ;;=^5000379
+85 ;;^UTILITY(U,$J,358.3,39925,0)
+86 ;;=A69.23^^152^2002^5
+87 ;;^UTILITY(U,$J,358.3,39925,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,39925,1,3,0)
+90 ;;=3^Arthritis d/t Lyme Disease
+91 ;;^UTILITY(U,$J,358.3,39925,1,4,0)
+92 ;;=4^A69.23
+93 ;;^UTILITY(U,$J,358.3,39925,2)
+94 ;;=^5000378
+95 ;;^UTILITY(U,$J,358.3,39926,0)
+96 ;;=A51.0^^152^2002^29
+97 ;;^UTILITY(U,$J,358.3,39926,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,39926,1,3,0)
+100 ;;=3^Genital Syphilis,Primary
+101 ;;^UTILITY(U,$J,358.3,39926,1,4,0)
+102 ;;=4^A51.0
+103 ;;^UTILITY(U,$J,358.3,39926,2)
+104 ;;=^5000272
+105 ;;^UTILITY(U,$J,358.3,39927,0)
+106 ;;=A52.3^^152^2002^54
+107 ;;^UTILITY(U,$J,358.3,39927,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,39927,1,3,0)
+110 ;;=3^Neurosyphilis,Unspec
+111 ;;^UTILITY(U,$J,358.3,39927,1,4,0)
+112 ;;=4^A52.3
+113 ;;^UTILITY(U,$J,358.3,39927,2)
+114 ;;=^5000298
+115 ;;^UTILITY(U,$J,358.3,39928,0)
+116 ;;=A52.10^^152^2002^53
+117 ;;^UTILITY(U,$J,358.3,39928,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,39928,1,3,0)
+120 ;;=3^Neurosyphilis Symptomatic,Unspec
+121 ;;^UTILITY(U,$J,358.3,39928,1,4,0)
+122 ;;=4^A52.10
+123 ;;^UTILITY(U,$J,358.3,39928,2)
+124 ;;=^5000291
+125 ;;^UTILITY(U,$J,358.3,39929,0)
+126 ;;=A52.9^^152^2002^49
